To determine if variant 3 accounts for the cellular CTHRC1 protein in melanoma cells, we knocked down the CTHRC1 expression with small interfering RNAs (siRNAs) specific to the full-length or variant 3 mRNA and with siRNAs targeting both splice variants. This evidence concerns the gene CTHRC1 and melanoma.